Stem Cell Therapy for Neurodegeneration

Migration, Crosslink

📖

Stem Cell Therapy for Neurodegeneration

active

wiki page Created: 2026-04-02T07:19:03 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-stem-cell-therapy-neur

📖 Wiki Page

therapeutic1070 wordssynced 2026-04-02

Stem Cell Therapy for Neurodegeneration

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Stem Cell Therapy for Neurodegeneration</th>
</tr>
<tr>
<td class="label">Trial/Program</td>
<td>Phase</td>
</tr>
<tr>
<td class="label">ESC-dopaminergic</td>
<td>Phase 1/2</td>
</tr>
<tr>
<td class="label">iPSC-dopaminergic</td>
<td>Phase 1</td>
</tr>
<tr>
<td class="label">MSC for MS</td>
<td>Phase 2/3</td>
</tr>
<tr>
<td class="label">NSC for ALS</td>
<td>Phase 1</td>
</tr>
<tr>
<td class="label">AHSCT</td>
<td>Phase 2/3</td>
</tr>
</table>

Introduction

Stem Cell Therapy For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Stem cell therapy represents a promising regenerative medicine approach for neurodegenerative diseases, aiming to replace lost [neurons](/entities/neurons), support dying cells, and restore neural circuits. Various stem cell types are being investigated for their potential to treat conditions including Parkinson's disease, Alzheimer's disease, ALS, and spinal cord injury[@stem]. [@clinical]

The field has advanced significantly, with several clinical trials demonstrating safety and early efficacy signals. Different stem cell approaches offer unique advantages and challenges[@clinical]. [@msc]

Types of Stem Cells

Embryonic Stem Cells (ESCs)

...

Stem Cell Therapy for Neurodegeneration

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Stem Cell Therapy for Neurodegeneration</th>
</tr>
<tr>
<td class="label">Trial/Program</td>
<td>Phase</td>
</tr>
<tr>
<td class="label">ESC-dopaminergic</td>
<td>Phase 1/2</td>
</tr>
<tr>
<td class="label">iPSC-dopaminergic</td>
<td>Phase 1</td>
</tr>
<tr>
<td class="label">MSC for MS</td>
<td>Phase 2/3</td>
</tr>
<tr>
<td class="label">NSC for ALS</td>
<td>Phase 1</td>
</tr>
<tr>
<td class="label">AHSCT</td>
<td>Phase 2/3</td>
</tr>
</table>

Introduction

Stem Cell Therapy For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Stem cell therapy represents a promising regenerative medicine approach for neurodegenerative diseases, aiming to replace lost [neurons](/entities/neurons), support dying cells, and restore neural circuits. Various stem cell types are being investigated for their potential to treat conditions including Parkinson's disease, Alzheimer's disease, ALS, and spinal cord injury[@stem]. [@clinical]

The field has advanced significantly, with several clinical trials demonstrating safety and early efficacy signals. Different stem cell approaches offer unique advantages and challenges[@clinical]. [@msc]

Types of Stem Cells

Embryonic Stem Cells (ESCs)

Characteristics: [@ipscderived]

Pluripotent: can differentiate into any cell type
Derived from early embryos
Ethical considerations limit clinical use

Applications: [@neural]

Dopaminergic neurons for Parkinson's disease
Motor neurons for ALS
Cholinergic neurons for Alzheimer's

Challenges:

Tumor formation risk (teratoma)
Immune rejection concerns
Ethical and regulatory barriers

Induced Pluripotent Stem Cells (iPSCs)

Characteristics:

Reprogrammed from adult somatic cells
Patient-specific (autologous)
Avoids ethical issues of ESCs

Advantages:

Patient-matched, reducing rejection risk
Can be derived from patient's own cells
Personalized medicine potential

Current Applications:

Autologous transplantation in Parkinson's
Disease modeling and drug screening
Personalized treatment approaches

Mesenchymal Stem Cells (MSCs)

Characteristics:

Multipotent: can differentiate into bone, cartilage, fat
Easily obtained from bone marrow, adipose tissue, umbilical cord
Immunomodulatory properties

Mechanisms of Action:

Paracrine signaling (releasing neurotrophic factors)
Immunomodulation and anti-inflammation
Support of endogenous repair mechanisms
May fuse with existing neurons

Clinical Applications:

Multiple sclerosis
Parkinson's disease
[ALS](/diseases/amyotrophic-lateral-sclerosis)
Stroke recovery

Neural Stem Cells (NSCs)

Characteristics:

Lineage-restricted to neural fates
Can self-renew and generate neurons, [astrocytes](/entities/astrocytes), oligodendrocytes
Present in specific brain regions

Applications:

Direct neuronal replacement
Support of endogenous neurogenesis
Delivery of therapeutic proteins

Clinical Applications by Disease

Parkinson's Disease

Cell Types Used:

ESC-derived dopaminergic neurons
iPSC-derived dopaminergic neurons
MSC transplantation

Clinical Trials:

Various Phase 1/2 trials showing safety
Some trials showing motor improvement
Long-term follow-up ongoing

Target Brain Regions:

Substantia nigra pars compacta
Striatum (putamen)

Alzheimer's Disease

Cell Types Used:

MSCs (most common)
NSCs
ESC-derived cholinergic neurons

Mechanisms:

Neurotrophic factor release
Modulation of neuroinflammation
Support of synaptic function
Potential amyloid/tau modulation

Challenges:

Integration into complex neural circuits
Targeting multiple pathological features
Disease staging for intervention

Amyotrophic Lateral Sclerosis (ALS)

Cell Types Used:

MSC transplantation
NSC transplantation
ESC-derived motor neurons

Approaches:

Intrathecal delivery
Intraspinal injection
Intravenous infusion

Goals:

Support motor neuron survival
Reduce neuroinflammation
Provide neurotrophic support

Clinical Results:

Generally safe in Phase 1/2 trials
Some studies show slowed progression
Variable outcomes across studies

Multiple Sclerosis

Cell Types Used:

MSCs (most extensively studied)
Hematopoietic stem cells (HSCT)

Mechanisms:

Immunomodulation
Remyelination support
Neuroprotection

HSCT Approach:

Autologous hematopoietic stem cell transplantation (AHSCT)
Used for aggressive, treatment-refractory MS
Requires chemotherapy conditioning

Delivery Methods

Surgical Implantation

Stereotactic injection into specific brain regions
Used for neuron replacement approaches
Precise targeting required

Intrathecal Delivery

Injection into cerebrospinal fluid
Used for MSC and NSC delivery
Distributes cells throughout CNS

Intravenous Infusion

Systemic delivery
Primarily used for MSCs
Cells may accumulate in brain under inflammatory conditions

Intranasal Delivery

Non-invasive approach
Direct nose-to-brain pathway
Currently in experimental stages

Clinical Trial Landscape

Challenges and Considerations

Safety Concerns

Tumor formation: Risk with pluripotent cells
Immune rejection: Especially with allogeneic cells
Seizures: Reported in some trials
Infection: Surgical delivery risks

Efficacy Limitations

Limited survival of transplanted cells
Challenges with circuit integration
Variable differentiation quality
Disease-specific considerations

Regulatory Issues

Complex manufacturing requirements
Personalized vs. off-the-shelf products
Long-term follow-up requirements

Biomarkers and Monitoring

Imaging Markers

PET imaging for cell survival
MRI for structural changes
Functional MRI for circuit restoration

Molecular Biomarkers

Neurofilament levels (NfL)
Inflammatory markers
Disease-specific markers

Clinical Endpoints

Motor function scales
Cognitive assessments
Quality of life measures

Future Directions

Gene-Edited Cells

CRISPR-corrected patient cells
Engineering enhanced survival
Chimeric antigen receptor (CAR) approaches

Biocompatible Scaffolds

3D printed neural tissues
Hydrogel-based cell delivery
Natural scaffold materials

Combination Therapies

Stem cells with neurotrophic factors
Cell therapy with rehabilitation
Stem cells with immunomodulatory drugs

Background

The study of Stem Cell Therapy For Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Allen Brain Atlas Resources

[Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
[Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
[Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury

External Links

[ClinicalTrials.gov - Stem Cell and Neurodegeneration](https://clinicaltrials.gov/search?cond=Neurodegenerative+Disease&intr=stem+cell)
[ISSCR - Stem Cell Research](https://www.isscr.org/)
[Parkinson's Foundation - Emerging Treatments](https://www.parkinson.org/)

References

[Unknown, Stem cell therapy for Parkinson's disease: current status and future directions (n.d.)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Unknown, Clinical applications of stem cells in neurodegenerative diseases (n.d.)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Unknown, MSC therapy for multiple sclerosis: clinical evidence (n.d.)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

Unknown, iPSC-derived neurons for disease modeling and therapy (n.d.)

Unknown, Neural stem cell transplantation: mechanisms and applications (n.d.)

📖 View canonical wiki page →

Related Entities

therapeutics-stem-cell-therapy-neurodegeneration

▸Metadataorigin_type: v1_polymorphic_backfill

slug	therapeutics-stem-cell-therapy-neurodegeneration
kg_node_id	None
entity_type	therapeutic
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-b826de4c0757
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'therapeutics-stem-cell-therapy-neurodegeneration'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

547

Outgoing

716

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Stem Cell Therapy for Neurodegeneration

Stem Cell Therapy for Neurodegeneration

Introduction

Overview

Types of Stem Cells

Embryonic Stem Cells (ESCs)

Stem Cell Therapy for Neurodegeneration

Introduction

Overview

Types of Stem Cells

Embryonic Stem Cells (ESCs)

Induced Pluripotent Stem Cells (iPSCs)

Mesenchymal Stem Cells (MSCs)

Neural Stem Cells (NSCs)

Clinical Applications by Disease

Parkinson's Disease

Alzheimer's Disease

Amyotrophic Lateral Sclerosis (ALS)

Multiple Sclerosis

Delivery Methods

Surgical Implantation

Intrathecal Delivery

Intravenous Infusion

Intranasal Delivery

Clinical Trial Landscape

Challenges and Considerations

Safety Concerns

Efficacy Limitations

Regulatory Issues

Biomarkers and Monitoring

Imaging Markers

Molecular Biomarkers

Clinical Endpoints

Future Directions

Gene-Edited Cells

Biocompatible Scaffolds

Combination Therapies

Background

Allen Brain Atlas Resources

See Also

External Links

References

💬 Discussion